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As reantly reviewed by krutinio et al. (I), the majority of 
stxlfes. ineluding the Unstable Angina Study Using Eminase 
(UNASEM) trial (2,3): showed that the clinical outcome in 
patientswith unstable angina is not influenced by thrombalytic 
therapy. In the UNASEM trial, 159 patients with typical 
unstable angina and iypical electrocardiographic (ECG) 
changes were included. After baseline comnnry angiography, 
pctients were randomly treated either with the thrombolytic 
apnt anistrcplax (eminasc or anisoylated plcsminogen strep- 
:okinasc activator mmplex [APSAC]) or with plaeeba. The 
study showed that anistrcplcse produced a significant decrease 
in the severity of the culprit lesion compared with placebo. 
However, clinical outcome was independent of thromboiytic 
treatment. 
This last finding $ pwding because it is well know that the 
in diamotrr &&is or to cl&al wtmloe (p = 0.98 and p = tI”k, 
mpectivalyl. TEe poww of these analyses to detect a 20% diPn* 
Therefaore. the cp&im remains whether s&ou~ can be 
identified in whom tbmmbalytie treatment i? heneticial. Some 
invcstigatun (7-9) found a relation between the presence or 
absence of thmmbus hxnmtian and the antio~uhic 01 clinical 
outcanc after thmmtdyiic therapy. Others-(P;10j reported that 
the type of i;sion might kdlucscc &Ml read& In the present 
study,wc rrtmspcztive~ im~estigcted hepassible r&of euronary 
sncromy and prcseoee of wmnay clot formation on clinical 
outcome in p&u& fmm the UNASEM trial. 
Methods 
Patients. One hundred fifty-nine patients were enrolled in 
the UNASEM trial. The trial was double blind, placebo 
controlled and randomized. The full proroco! Lss hew pub 
lishcd elsewhere (2). Patients had to fulfill the following 
inclusion criteria: 1) a typical history of unsiahle angina 
defined its a) ongina at rest OT on minimal exercise; h) angina 
of recent onset (~4 weeks); c) the last episode of chest pain 
within 12 h before admission; and 2) ECG abnormalities 
suggestive of ischemia ) in patients with chest pain before hut 
not after admission, Ihc presence of ST segment dcprcssion or 
the so-called high left anterior descending coronary artcly 
pattern (11). showing terminal negative T waves in the precor- 
dial lcads: or b) in patients with chest pain during hospital 
admisston, temporary ST segment changer (elevation, depres- 
sion or pseudonormalization). 
The exclusion criteria were age <30 or >70 yean; previous 
myocardial infarction or previ&s cardiac surgery or angio- 
play: nonischemic ST segment changes (as in left ventricular 
hypertrophy): contraindications for ~hrornbolytic therapy: or 
absence of informed consent. 
After inclusion in !he study, the pa:ients were randomized 
to the trial medication (either anistreplsse or plxebo). but 
treatment was postponed until after the baseiine angiogram. 
Cardiac catheterization. Ltaseline angiugraphy, including 
coronary and left ventricular angiography, was performed 
within 3 h after inclusion in the study. Angiography was 
repeated after I2 to 28 h. To identify the location of the culprit 
Iesion. the following criteria were used: I) in case of singk- 
vessel disease. the most severe l sion in that arten’: 2) in case 
of multivessel disease, the location of coronary &e& abnar- 
malitv correswndine to the ECG abnormalities. For examolc. 
deveiopment’of negative T waves in precardial eads ws t&i 
as typical for leh anterior deaending coronaty artery perfusion 
prohkmr. If the ECG was inconclusive, the location of left 
ventricuhtr wall motion abnormalities (if present) was used to 
identify the culprit artery. 3) If UY of the first two criteria was 
inconclusive, the stenosis howing clear changes between the 
baseline and the posttreatment angiogram was taken to be the 
culprit I&n. 
The criteria of Ambrose (7.12) were used to classify the 
type of lesion and the presence of coronary thrombus. Because 
of the limited number of patients in this study, we classified the 
lesions as only two types (Fig. I): rype A (concentric lesion) = 
symmetric narrowing with smooth or slightly irregular borders: 
and qpe B or C (mmpler lesion) = eccentric stenosis with 
asymmetric narrowing of the culprit lesion or multiple irregu- 
larities. 
The culprit lesion was determined during the firs! angiog- 
rttphy. If an occluded artery was present, the type of lesion 
could not be identified. If this vessel reopened, the type of 
lesion wus determined in the second angiography. 
If the artery at the baseline angiogram WIE open, an 
intmcoronnry tlwo!ubtrs was defined as a filling defect located 
proximnl to, within or distal to a culprit stenosis urrounded by 
contrast medium on at least hree sides and visible in multiple 
projections (Fig. 2). Not uncommonly, these filling defects 
moved up and down during the cardiac cycle. Occluded 
artcrieb during the first angiugram were presumed to contain 
thrombus material (Fit. 3). 
Angiographic assessment and classification were performed 
in blinded tn.mner by ncommittee with angiographic expertise. 
Van den Brand ct al. (13) stated that quantitatiwe analysis of 
coronary arteries in unstable angina is the most sensitive 
method of detecting changes in diameter stenosis or other 
characteristics 01 the lesion. Therefore, quantitative rneawre- 
ments were made using the Cardiovascular Angioplasty Anal- 
yds (CAAS) system (14). Analysis of the !&on was based on at 
least two projections. Impmwment of a coronary lesion *a5 
defined as adecrease in diameter stenosis b-etween the first and 
the second angicgramr, measured by the CL&S rystern. 
Wal medication and ctmcnmitaut tt’ertment. After an- 
giography, trial medication wtts withheld in paents with main 
~tetn disease ~70%. normal or nonsignificant coronary anety 
disease or development of myocardial infarction before the 
start of medication. 
Trial medication consisted of 30 U uf intrsvenous anis- 
treplase or placebo and WE given over 5 min after the 
pretreatment angiogram had been made An intravenous drip 
of nitroglycerin was started before the pretreat~tent angiugw. 
phy; S,aoO U of intravenous heparin was injected during 
baseline angiography and cuntinuLd with a starting dose of 
1,oMI Uih. Further titration ws done depending on the 
activated partial thromboplartin time. Aspikm io a dose of 
303 mg once daily was started after the posttreatment angio- 
Statistics. iVbm applaable. n Fisher ehxt test. Srudcnt 
f test or chi.squaw test (without Yatcr correction) was per- 
formed. Two.tailed p values :!re reported. Significance was 
defined asp < 0.05. 
In total, IS9 patients WEE included in the study (Table I). 
Thirty.three of IS9 patients did not receive study medication 
be&r of exclusion~criteria or other ~eaons (se&e left main 
stem stenosis [7 patients], normal coronary arteries [ 17 pa- 
tients], myocardial infarcuon occurring before IIIE start of 
study medication 14 patients], severe groin bleeding [2 pa- 
tients], technical problems preventing catheterization [? pa- 
tients], cardtogens shock (I patient]). Of the remninmg I26 
patients, 65 wex iandomizcd to ~cccivc dnistrrplasr and 61 
placebo. We were unable to dctemtinc rhc presence or abxocc 
of thrombus formation in fiw @ems. and an additwnal two 
patients did not have two angiograms. This resulted in a total 
of 119 of 126 treated patients in whom thromhcs formation 
could he analyzed. The type of lesion could not be drtermmed 
in 20 patients (nomxtl artery [I patient]. occluded artery [I6 
patients], not identified [3 pattents]), and one other patient had 
only one angiograw. This resulted in IQ5 of .he I?6 treated 
patients in whom the type of lesion cou!d be analyzed. Table 2 
shows the number of patrents av&hle for each anslysa. 
Decrease io coronary artep stenosis. As previously ic- 
ported (Z), a significant decrease in stenosis severity (p = 
0.002) was found in the xdstreplasc-treated group compared 
with the placebo-treated gruup by qualitztiw assesunent. 
Ouantitawe C4AS analysis howed identical results: Dlame- 
tcr \tcnosis decreased 11% in patients treated witb anis- 
trrplase versus 3% in patients receiving placebo (p = O.OOS). 
Seventeen of 65 anistreplnse-treated patients and I I of hl 
placebo-treated patients had an occluded artery at barclinc 
angiography: in all of these patients. collateral vessels provided 
blood supply to the iscbemic area. The ditTerence in degree of 
stenosis be ; re ad &U study mcdicntion was the result of the 
reopenicg ,)f I? of 17 occluded artcries in the anirtreplase- 
treated pauents. whereas none of the coronary arteries re- 
opened in the I1 placebo-treated patients. The drcrense m 
dxmwrer srrnosis afopen arteries betwren the tint and xcond 
anpiosraphy was 5% in the aliirtreplosc.neatcd group com- 
pad wrh 3% in the placebo-treated group (p = NS) (2). 
5~ of culprit lesion or presence of thmmbus and angiu- 
graphic outcome. The type of culprit lesion could be classified 



















be concentric, and in 30 (29%) eccentric or complex. In 119 
patients the presence or absence of thrombus could be ana- 
lyzed. Aclearlhrombuswas visible in 39of them (33%). In the 
remaining 80 patients (67%). the prerena of thmmbus could 
not be determined by the criteria mentioned previously in the 
Methods section. Neither the type of laion (concentric or 
complex) nor the prose-ce or absence of thmmbus influenced 
the angiagraphic outwtne of the second cathctcrization (p = 
0.96 and p = 0.95). The pmer of the lest to detect a 20% 
higher or lower incidence of improved coronaty anatomy in 
concentric vcrs~~s eccentric lesions was 51% and 56%. respec. 
tivrly. The power to detect these diUcrcnccs in ca?.cs where the 
thmmbus was visible versus casts whore the thrombus was not 
visible was 65% in both situations These resuI(s were in&- 
pendent of type of study medication (Table 3). 
Type of lesion or pnrena d lhmmtw and dialcal at- 
cmtte. lluring hospital admission, cardiac cventS (defined as 
mortality, mywrdial infarction, recurrence of angina, need 
Tabk L Patients Available for Anabsis 
for bypw graft or angioplasty) were common. Sithrce 
pcncnt of patients had at least one of these events. We 
previousiy rcpxted (2) that in the total group of patients 
angkgmphii outcome w.5 indcpcndcnt of clinical outmme. 
The anatomic chwxteristks (type of ksion or presence of 
thmmbw) were not related to the occumnee of any cardiac 
ewnt or the type of event (death, myccardial infarction, 
coronary artery bypass SurgeBy, aneiaplasty or angina) (p = 
0.77 and p = 0.90). The pmcr of the test to detect a 20% 
higher or lower iwidence ofeardkc evcttts ittmneetttricvetw. 
eacntric ksions was 70% and 65%, rupxtivciy. These figures 
for visibk versus nomfsibk thmmbau wcte 72% and 74%. 
rcspxtiveiy. These rwllp were again indepmdcnt of study 
medication (Tabk 4). 
p Yd”C 
Discussion 
Trpe of lesion. Ambrose et al. (I?) defined a number cf 
typicai anatomic variations in the &onary artrrics in patents 
with unsrablr aneina. Recentlv. thev simdihed these critcrla 
(7). In the p&t study. thi; last~sc! df criteria WI used. 
Freeman et al. (8) used the first-mentioned Ambrose et al. 
criteria when they prospectively studied the coronary ana!omy 
in 80 patients with unstable angina. In that srudy. complex 
morphology of the culprit lesion was seen in -40% of the 
pati&. They concluded that the presence of B complex IeGo 
predicted a worse clinical outcome. Thev stated that in most of 
ihese lesions thrombus formation was likely to be present. Ellis 
e! al. f10). wine mulrivariate anslvsis. also indicated that 
roughn&s’and le$h of the culprit iesion strongly predicted 
risk of mvacardial infarction. The tindinps of rhesc two studa 
disagree with our obsewation:. where !he !ype of culprit lebion 
had no predictive value 8s to clinical outcome. In addition. 
plaque morphology did not discriminate for angiographic 
impmvcmen! in our study. The recently published Thrombol- 
yris in Myoeardial Infarction (TIMI) IllA study (9). performed 
in a sizable number of patients. also indicated that no sigcili- 
cant relation was found between the type of the culprit lesion 
and angiographic outcome. 
Thmmbnis_ Coronary thrombosis plays an importnnt role 
in unstable angina. This has been shown by angiugnphy, 
angioscopy. autopsy and indirectly by biochemical eramina- 
tions and effect of treatment (9,ljJY). In those studies. the 
frequency of rhrombus formation varied between 1% ad 85%. 
This wide variation can be emlained bv Ihe Iimine and twc of , - . 
the investigation and the cri$ria used (3). For example, it has 
been reported (4-6) !hs! the presence of thrombus is depen- 
dent on the delay between onset of complai::s rind cardiac 
catheterization: The incidence of observing lhrombi is m- 
versely related to the time from rpprarance of symptoms until 
angiography. In our trial, patients were studied in the ilcute 
phase of unsoble angina. However, even after patients wirh 
eluded an&s had been included, only 33% of the patients 
had definite evidence of thrombi in the pretreatment angio- 
gram. Van den Brand et al. (13) reported a visible thrombus in 
4 of 36 paliems with unstable angina; an additional 3 patients 
had an occluded ar!ery that was suggcrtive of thrombosis. Our 
findmg< corrc?pond with we TIMI 111.4 resulf~. In that radg 
(IO). apparent thmmbus ws observed in 3X of all culprit 
leslonr. incWinp 9% of patients who had ar. occluded artery 
That study had inclusion criteria and time delays sir&r to 
LINASFB! Freeman et al. (8) found a 43% mudcnce o? 
rhrombus formation in angiogams made within 24 h after 
admission. The incidence decreased to 21% in mgiograms 
made iarer that week, however, patients with ongoing chest 
pain showed thrombus formation in Wk of casts. Thus. 
pcrccnt of thrombosis is rnosr certainly influenced by the 
crileria dcfininp thrombus formation, $pe of patients and 
timllp uf the angiogram. ? hese criteria vary from study to 
study. rewlttng in marked differences in the incidence of 
thrombus formation. 
Ggtuh et al. (17) found agiqmphic improremcn! attcr 
thrombolytic rrearmen! in 20 of 21 patientswith thrombus. The 
UNASEM lrial confirmed that coronary anatwny improws 
after rhrowbolytic therapy (2). Howsver. angiognphic im- 
prowment \\as seen only in patients with occluded anerier. in 
whom rhromhosis is likely 10 be prcxnt. This is in line with the 
TlMl IllA findings (9). where the zngiographic rharxteristics 
favoring measurable improwmenr included a rccex corussry 
occlusion. Podenfs with open arteries did not have a helter 
angiqraphic outcome after thrombolytic treatment in our 
study 9s in TIM1 WA. This findin was independent of Ihe 
presence or absence of intraluminary thrombi. Scrutinio et 31. 
(1: rLviewcd data on the clin’cal outcome from seven studies 
and found [hat Vetrovec et al. (5) wcrc the only investigators 
to report a beneficial clinical outcome after thrombolpic 
therapy. Smell pilot studies su_~est that lhrombolysis might be 
more effcciive if a longer infusion duration is used (WI). 
The UNAShM trial confirms that thrombolytic therapy is 
climcally mcli’ective in the total group of patients. Also. in 
patients with coronary thromhoais. no sipniticnnt ditTcrcnce in 
cliilicid outcome WI feud. 
I! is tempting to speculate on possible explanations fol the 
ktek of unprovement after thrombolytic thrwpy in patients 
with unstable angina. They include the follwving: 
1. Plawic! a~rrgation is no! a(fec!ed in vessels containing 
thrombun.Thrombolytic agents do lyse clots but do nor inhibit 
platelet sgpregation. The angioscopic appearance of the 
thrombus in patientswith unstable sngina is different from thl!t 
in patients with acute myocardial infarction (6.18). !P mgacar- 
dial inhrction, a red thmmbus is :ommunly found. In unatahle 
angina. most patients show a gray thrombus, which ~ugyests 
that the thrombus is already older and covered by platelet 
deposits. Such older thrombi might thcrcfore dissolve lees atier 
lhrombolytic therapy. 
2. Some thrombolytic agents may ultimately cause platelet 
activation and thrombus formauon in viva, possibly throuqh 
plarmin (19). Plasmin can activate platelet aggregation and 
Factor V directly. This may liwil lhrombolysis in unstable 
angina. Plate& increase the rcristance of thrombi to lysis by 
inducing clef retwzlion and crowhnking and by releasing 
inhibitors (20). 
3. A small decrease in stenosis of an open artery is rtwrc 
difficult to detect than reopening of ai occluded arteq: 
Reopenin% even to a minor dwee. leads to a clearly visible 
ang&graphic ditTerence. 
4. In contract to myocardial infarction, pathogenesi., of 
unstable angina is more complex (42). It most certainly cannot 
be explained by thromhur formation an P ruptured plaque 
alone. A gradual increase in a stable atherwieroric piaque can 
lcad to u&able angina. A recent study from Flugeimsn et al. 
(43) is indeed suggestive of this. They performed (immune) 
histopathologic investigations of 32 patients atherectomy spcc- 
imens from patients with unstable angina. in 56% of these 
patients, smwth muscle cell proliferation had led to plaque 
cxpaneion and thereby to lumen narrowing and unstable 
angina. Also. a spastic component in the coronary attely could 
play a role in the instability of some cases (3V.7.38). 
S. Thrombosis is a dynamic process ifi which a delicate 
interplay between thrombosisand thrombnlysis, migration with 
or without disintegration of thrombus and platelet agyegation 
and inhibition Slav a role. In addition. local intimal dissections. 
gradual intimsi g&ah and spesm f&her complicate the locai 
pVXeSS. 
6. Recent data suggest hat only half of the lesions asseejsed 
have concordant morphologic, angiogsaphic and ultrasound 
findings (44). Angiuscopic result. indicate that angiography 
might also be misleading in the diagnorir of an intimal flap or 
thrombus (45,46). Thus. the% new techniques show that 
angiography has wcrc limitations and prohahly should no 
longer be used as the rc:cwnce standard. 
Study iimitations. The complex patbogbysiolopy of unsta- 
ble angina seems to he rcspunsible fdr the &ppoi&gresults 
of thrombolytic therapy. Some limitations of the study were 
diwwcd ear!ier. Most important, angiagraphic proof of 
thrombus is still difficult. In addition, this was a retrospective 
analysis, and the UNASEM protocol was not specifically 
designed to address the items I lo 6. Finally, although larger 
than in most of the other studies. the number of patients 
included in this trial was limited, making it imp&ible to 
analyze all expects with sufficiently large numbers of patients. 

